Whitsell Innovations, Inc. to attend the 2023 Diversity Alliance for Science East Coast Conference

Whitsell Innovations, Inc. to attend the 2023 Diversity Alliance for Science East Coast Conference

FOR IMMEDIATE RELEASE:

Chapel Hill, NC – April 2023 – Whitsell Innovations, Inc. to attend the 2023 Diversity Alliance for Science (DA4S) East Coast Conference.

Whitsell Innovations (WI), Inc., is pleased to announce that our President, Robin Whitsell, will be attending the 2023 Diversity Alliance for Science (DA4S) East Coast Conference in Newark, New Jersey on May 2-4, 2023.

Robin serves on the DA4S Membership Committee and hosts the monthly virtual Members Lounge with Shirley Tang‑Audritsh of Eli Lilly.

The DA4S East Coast Conference provides attendees with the opportunity to effectively network and build relationships in an intimate setting. The conference features top-level pharmaceutical executives, CEOs of diverse scientific and clinical enterprises, and other guest speakers.

DA4S is a networking organization for small and/or diverse businesses within the life science and healthcare industries. DA4S hosts events and forums to foster connections between these businesses and larger corporations, academic institutions, and governmental agencies. DA4S also supports its members through programs for mentorship and leadership, business acceleration, and innovation.

Website: https://diversityallianceforscience.com/

ABOUT WHITSELL INNOVATIONS, INC.
WI is a Women’s Business Enterprise National Council (WBENC) certified woman owned full-service medical and scientific writing company headquartered in Chapel Hill, North Carolina.

Contact: info@whitsellinnovations.com
Website: www.whitsellinnovations.com

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties, and other factors not under the company’s control. Whitsell Innovations, Inc.’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward‑looking statements.